Literature DB >> 15956184

Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques.

Kimmo Virtaneva1, Stephen F Porcella, Morag R Graham, Robin M Ireland, Claire A Johnson, Stacy M Ricklefs, Imran Babar, Larye D Parkins, Romina A Romero, G Judson Corn, Don J Gardner, John R Bailey, Michael J Parnell, James M Musser.   

Abstract

Identification of the genetic events that contribute to host-pathogen interactions is important for understanding the natural history of infectious diseases and developing therapeutics. Transcriptome studies conducted on pathogens have been central to this goal in recent years. However, most of these investigations have focused on specific end points or disease phases, rather than analysis of the entire time course of infection. To gain a more complete understanding of how bacterial gene expression changes over time in a primate host, the transcriptome of group A Streptococcus (GAS) was analyzed during an 86-day infection protocol in 20 cynomolgus macaques with experimental pharyngitis. The study used 260 custom Affymetrix (Santa Clara, CA) chips, and data were confirmed by TaqMan analysis. Colonization, acute, and asymptomatic phases of disease were identified. Successful colonization and severe inflammation were significantly correlated with an early onset of superantigen gene expression. The differential expression of two-component regulators covR and spy0680 (M1_spy0874) was significantly associated with GAS colony-forming units, inflammation, and phases of disease. Prophage virulence gene expression and prophage induction occurred predominantly during high pathogen cell densities and acute inflammation. We discovered that temporal changes in the GAS transcriptome were integrally linked to the phase of clinical disease and host-defense response. Knowledge of the gene expression patterns characterizing each phase of pathogen-host interaction provides avenues for targeted investigation of proven and putative virulence factors and genes of unknown function and will assist vaccine research.

Entities:  

Mesh:

Year:  2005        PMID: 15956184      PMCID: PMC1150296          DOI: 10.1073/pnas.0503671102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection.

Authors:  C D Ashbaugh; T J Moser; M H Shearer; G L White; R C Kennedy; M R Wessels
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

2.  Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.

Authors:  M Collin; A Olsén
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Authors:  J J Ferretti; W M McShan; D Ajdic; D J Savic; G Savic; K Lyon; C Primeaux; S Sezate; A N Suvorov; S Kenton; H S Lai; S P Lin; Y Qian; H G Jia; F Z Najar; Q Ren; H Zhu; L Song; J White; X Yuan; S W Clifton; B A Roe; R McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response.

Authors:  Paul Sumby; Kent D Barbian; Donald J Gardner; Adeline R Whitney; Diane M Welty; R Daniel Long; John R Bailey; Michael J Parnell; Nancy P Hoe; Gerald G Adams; Frank R Deleo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

6.  Transcriptome of uropathogenic Escherichia coli during urinary tract infection.

Authors:  Jennifer A Snyder; Brian J Haugen; Eric L Buckles; C Virginia Lockatell; David E Johnson; Michael S Donnenberg; Rodney A Welch; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Global differential gene expression in response to growth temperature alteration in group A Streptococcus.

Authors:  L M Smoot; J C Smoot; M R Graham; G A Somerville; D E Sturdevant; C A Migliaccio; G L Sylva; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 8.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

9.  Transcriptome profiles of host gene expression in a monkey model of human malaria.

Authors:  Joni Ylostalo; Amber C Randall; Tereance A Myers; Michael Metzger; Donald J Krogstad; Frank B Cogswell
Journal:  J Infect Dis       Date:  2004-12-22       Impact factor: 5.226

10.  [Cardiolipin antibodies in acute rheumatic fever].

Authors:  B S Dzhuzenova; E L Nasonov; V Iu Kovalev; O V Lopaeva; A I Speranskiĭ; V A Nasonova
Journal:  Klin Med (Mosk)       Date:  1992-02
View more
  118 in total

1.  An amino-terminal signal peptide of Vfr protein negatively influences RopB-dependent SpeB expression and attenuates virulence in Streptococcus pyogenes.

Authors:  Samuel A Shelburne; Randall J Olsen; Nishanth Makthal; Nicholas G Brown; Pranoti Sahasrabhojane; Ebru M Watkins; Timothy Palzkill; James M Musser; Muthiah Kumaraswami
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

2.  Distinct time-resolved roles for two catabolite-sensing pathways during Streptococcus pyogenes infection.

Authors:  Colin C Kietzman; Michael G Caparon
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  Comparative Transcriptomic Response of Primary and Immortalized Macrophages to Murine Norovirus Infection.

Authors:  Eric A Levenson; Craig Martens; Kishore Kanakabandi; Charles V Turner; Kimmo Virtaneva; Monica Paneru; Stacy Ricklefs; Stanislav V Sosnovtsev; Jordan A Johnson; Stephen F Porcella; Kim Y Green
Journal:  J Immunol       Date:  2018-05-07       Impact factor: 5.422

Review 4.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.

Authors:  James M Musser; Frank R DeLeo
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Unraveling the regulatory network in Streptococcus pyogenes: the global response regulator CovR represses rivR directly.

Authors:  Samantha A Roberts; Gordon G Churchward; June R Scott
Journal:  J Bacteriol       Date:  2006-09-08       Impact factor: 3.490

6.  Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2.

Authors:  Izabela Sitkiewicz; Michal J Nagiec; Paul Sumby; Stephanie D Butler; Colette Cywes-Bentley; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

7.  The Seventh International Conference on the Genetics of Streptococci, Lactococci, and Enterococci.

Authors:  Robert A Burne; Debra E Bessen; Jeffery R Broadbent; Jean-Pierre Claverys
Journal:  J Bacteriol       Date:  2006-09-29       Impact factor: 3.490

8.  Developmental transitions of Coxiella burnetii grown in axenic media.

Authors:  Kelsi M Sandoz; Daniel E Sturdevant; Bryan Hansen; Robert A Heinzen
Journal:  J Microbiol Methods       Date:  2013-11-25       Impact factor: 2.363

Review 9.  RNA profiling in host-pathogen interactions.

Authors:  Simon J Waddell; Philip D Butcher; Neil G Stoker
Journal:  Curr Opin Microbiol       Date:  2007-06-15       Impact factor: 7.934

10.  Streptococcus pyogenes CovRS mediates growth in iron starvation and in the presence of the human cationic antimicrobial peptide LL-37.

Authors:  Barbara J Froehlich; Christopher Bates; June R Scott
Journal:  J Bacteriol       Date:  2008-11-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.